RA MEDICS
The computed 12-month bankruptcy probability of RA MEDICS is 5.3% (elevated). The 2024 annual accounts show equity of €28k and a net result of €26k. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €28k |
| Net result | €26k |
| Active | 2 yrs |
| Locations | 1 |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €34k |
| Net profit | €26k |
| Cash flow | €27k |
| Staff costs | - |
| Income taxes | €8k |
| Dividends | €833 |
| Total assets | €40k |
| Equity | €28k |
| Debt | €12k |
| of which ≤ 1y | €12k |
| of which > 1y | - |
| Working capital | €26k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.20 |
| Quick ratio | 3.20 |
| Working capital ratio | 64.9% |
| Solvency | 70.5% |
| Debt / equity | 0.42 |
| Long-term debt ratio | - |
| Interest coverage | 66.83 |
| Gross margin | - |
| Net margin | - |
| ROA | 66.4% |
| ROE | 94.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €40k |
| Fixed assets | 21/28 | €2k |
| Tangible fixed assets | 22/27 | €1k |
| Financial fixed assets | 28 | €1k |
| Current assets | 29/58 | €38k |
| Amounts receivable within one year | 40/41 | €14k |
| Cash & bank | 54/58 | €21k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €40k |
| Equity | 10/15 | €28k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €26k |
| Amounts payable | 17/49 | €12k |
| Amounts payable within one year | 42/48 | €12k |
| Trade debts payable within one year | 44 | €270 |
| Income statement | ||
| Gross operating margin | 9900 | €36k |
| Operating result | 9901 | €34k |
| Financial income | 75 | €447 |
| Financial charges | 65 | €514 |
| Result before taxes | 9903 | €34k |
| Income taxes | 67/77 | €8k |
| Net result for the period | 9904 | €26k |
| Result to be appropriated | 9905 | €26k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 01-03-2024 |
| Status | Active |
| Postal code | 1050 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21372C0137/00A000 | Brussels | 6,474 m² | 1 · 1,481 m² | 16.6 m · 5 fl. |
| 21807G0148/00Z003 | Brussels | 520 m² | 1 · 238 m² | 31.9 m · 10 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
30-12-2025 Registered office moved from Evere to Ixelles
- Avenue des Communautés 4, 1140 Evere → Avenue Louise 284, 1050 Ixelles
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Ixelles",
"region": "Brussels",
"street": "Avenue Louise",
"country": "BE",
"postcode": "1050",
"box_number": null,
"street_number": "284"
},
"old_address": {
"city": "Evere",
"region": "Brussels",
"street": "Avenue des Communaut\u00E9s",
"country": "BE",
"postcode": "1140",
"box_number": "032",
"street_number": "4"
},
"effective_date": "2025-11-14",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide que le si\u00E8ge de la soci\u00E9t\u00E9 sera transf\u00E9r\u00E9 de 1140 Evere, Avenue des Communaut\u00E9s 4/032 \u00E0 1050 Ixelles, Avenue Louise 284, et ce \u00E0 partir du 14/11/2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1006.660.555",
"name_full": "RA MEDICS",
"legal_form": "SRL"
}
}05-03-2024 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1140 Evere, Avenue des Communaut\u00E9s 4 bte B032",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1994-01-17",
"name": "ALLAGUI Raoua",
"niss": null,
"address": "1140 Evere, avenue des Communaut\u00E9s 4/B032"
},
"share_class": "actions",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "ALLAGUI Raoua",
"is_subscriber_only": true,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "1006.660.555",
"name_full": "RA MEDICS",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2024-02-26",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | RA MEDICS |